Helvetia Baloise Holding AG (LON:0ACB)
201.82
-1.14 (-0.56%)
At close: Dec 16, 2025
LON:0ACB Revenue
Helvetia Baloise Holding AG had revenue of 4.93B CHF in the half year ending June 30, 2025, with 6.38% growth. This brings the company's revenue in the last twelve months to 9.66B, up 2.50% year-over-year. In the year 2024, Helvetia Baloise Holding AG had annual revenue of 9.57B with 3.71% growth.
Revenue (ttm)
9.66B CHF
Revenue Growth
+2.50%
P/S Ratio
1.13
Revenue / Employee
654.85K CHF
Employees
14,758
Market Cap
10.02B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.57B | 342.50M | 3.71% |
| Dec 31, 2023 | 9.23B | 974.20M | 11.80% |
| Dec 31, 2022 | 8.25B | -4.24B | -33.96% |
| Dec 31, 2021 | 12.50B | 2.26B | 22.13% |
| Dec 31, 2020 | 10.23B | -358.30M | -3.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |